Overview

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

Status:
ENROLLING_BY_INVITATION

Trial end date:
2025-08-30

Target enrollment:

Participant gender:

Summary

Patient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessed

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Dr ayesha wahid

Treatments:

calcipotriene
Tacrolimus